Abstract
The global corona virus disease 2019 (COVID-19) pandemic has led to intense activity to develop an effective vaccine. In addition, there have been efforts to develop therapeutics to treat symptoms of the disease, reduce the severity of infection, or prevent infection entirely. Inspired by the potential of structure-based therapeutic design, research has led to detailed molecular models of key protein structural components of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virion (1).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
